Skip to main content

Advertisement

SpringerLink
Log in

Biochanin A and CPe-III Peptide Improved Hepatic Inflammation by Regulating the Hepatic Lipid Metabolic Pathways in Diet-Induced Obese Mice

  • Research Article
  • Published:
Transactions of Tianjin University Aims and scope Submit manuscript

Abstract

Biochanin A (BCA) and CPe-III peptide, which both exist in chickpea (Cicer arietinum L.), possess significant antihyperlipidemic properties. However, the actual mechanisms of those compounds in inhibiting the dysregulation of lipid metabolism and complicated inflammation have not been well characterized. This study investigated the effects of BCA, CPe-III peptide, and combined BCA and CPe-III peptide (BC) on the expression of genes involved in hepatic lipid and inflammation metabolism. Results demonstrated that BCA, CPe-III peptide, and BC significantly attenuated hepatitis and hyperlipidemia by downregulating those genes involved in pro-inflammatory cytokines (TNF-α), hepatic fatty acid (FA) synthesis (ACC1 and FAS), cholesterol metabolism (SREBP2, HMGCR, and PCSK9), and upregulating key regulators involved in FA oxidation (PPARα and FABP1), lipolysis (ATGL), LDLR, reverse cholesterol transport (ABCA1, SR-B1, and LXRα), and cholesterol catabolism (CYP7A1). Moreover, they also altered the expression of lipid metabolism-related proteins, including SREBP2, PCSK9, LDLR, ABCA1, and CYP7A1. Finally, these results revealed that the combination treatment of BCA and CPe-III peptide resulted in greater antihyperlipidemic activity compared with individual compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. De Sereday MS, Gonzalez C, Giorgini D et al (2004) Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab 30(4):335–339

    Article  Google Scholar 

  2. Kwon EY, Jung UJ, Park T et al (2015) Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes 64(5):1658–1669

    Article  Google Scholar 

  3. Maggo SDS, Kennedy MA, Clark DWJ (2011) Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf 34(1):1–19

    Article  Google Scholar 

  4. Wang KL, Liu CJ, Chao TF et al (2012) Statins, risk of diabetes, and implications on outcomes in the general population. J Am Coll Cardiol 60(14):1231–1238

    Article  Google Scholar 

  5. Afman L, Müller M (2006) Nutrigenomics: from molecular nutrition to prevention of disease. J Am Diet Assoc 106(4):569–576

    Article  Google Scholar 

  6. Mao J, DeMayo FJ, Li HG et al (2006) Liver-specific deletion of acetyl-Coa carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA 103(22):8552–8557

    Article  Google Scholar 

  7. Semenkovich CF (1997) Regulation of fatty acid synthase (FAS). Prog Lipid Res 36(1):43–53

    Article  Google Scholar 

  8. Lu YF, Xu YY, Jin F et al (2014) Icariin is a PPARα activator inducing lipid metabolic gene expression in mice. Molecules 19(11):18179–18191

    Article  Google Scholar 

  9. Muoio DM, Maclean PS, Lang DB et al (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Evidence for compensatory regulation by PPARα. J Biol Chem 277(29):26089–26097

    Article  Google Scholar 

  10. Feingold KR, Adi S, Staprans I et al (1990) Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Am J Physiol 259(2):177–184

    Google Scholar 

  11. Popa C, Netea MG, van Riel PLM et al (2007) The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48(4):751–762

    Article  Google Scholar 

  12. Chen ZY, Jiao R, Ma KY (2008) Cholesterol-lowering nutraceuticals and functional foods. J Agric Food Chem 56(19):8761–8773

    Article  Google Scholar 

  13. Sato R (2010) Sterol metabolism and SREBP activation. Arch Biochem Biophys 501(2):177–181

    Article  Google Scholar 

  14. Guo YL, Zhang W, Li JJ (2014) PCSK9 and lipid lowering drugs. Clin Chim Acta 437(1):66–71

    Article  Google Scholar 

  15. Chiang JYL (2009) Bile acids: regulation of synthesis. J Lipid Res 50(10):1955–1966

    Article  Google Scholar 

  16. Bonamassa B, Moschetta A (2013) Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol Metab 24(3):120–128

    Article  Google Scholar 

  17. Khalil A, Berrougui H, Pawelec G et al (2012) Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer’s disease. Mech Ageing Dev 133(1):20–29

    Article  Google Scholar 

  18. Harini R, Sundaresan A, Pugalendi KV (2012) Antihyperlipidemic effect of biochanin A on streptozotocin induced diabetic rats. J Pharm Res 5(1):707–710

    Google Scholar 

  19. Park HS, Hur HJ, Kim SH et al (2016) Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Mol Nutr Food Res 60(9):1944–1955

    Article  Google Scholar 

  20. Xue ZH, Gao J, Zhang ZJ et al (2012) Antihyperlipidemic and antitumor effects of chickpea albumin hydrolysate. Plant Food Hum Nutr 67(4):393–400

    Article  Google Scholar 

  21. Kou XH, Gao J, Xue ZH et al (2013) Purification and identification of antioxidant peptides from chickpea (Cicer Arietinum L.) albumin hydrolysates. LWT-Food. Sci Technol 50(2):591–598

    Google Scholar 

  22. Miller L (2010) Analyzing gels and western blots with ImageJ. Lukemiller. Org. http://lukemiller.org/index.php/2010/11/analyzing-gels-and-western-blots-with-image-j/. Accessed 1 Mar 2016

  23. Norris GH, Porter CM, Jiang C et al (2017) Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. J Nutr Biochem 40:36–43

    Article  Google Scholar 

  24. Zhang RJ, Yu Y, Hu S et al (2016) Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. Nutr Res 36(9):1022–1030

    Article  Google Scholar 

  25. Lira FS, Rosa Neto JC, Antunes BMM et al (2014) The relationship between inflammation, dyslipidemia and physical exercise: from the epidemiological to molecular approach. Curr Diabetes Rev 10(6):391–396

    Article  Google Scholar 

  26. Galli C, Calder PC (2009) Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 55(1–3):123–139

    Article  Google Scholar 

  27. Navab M, Anantharamaiah GM, Fogelman AM (2005) The role of high-density lipoprotein in inflammation. Trends Cardiovas Med 15(4):158–161

    Article  Google Scholar 

  28. Breikaa RM, Algandaby MM, El-Demerdash E et al (2013) Multimechanistic antifibrotic effect of biochanin A in rats: implications of proinflammatory and profibrogenic mediators. PLoS ONE 8(7):e69276

    Article  Google Scholar 

  29. Boden G, She PX, Mozzoli M et al (2006) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 54(12):3458–3465

    Article  Google Scholar 

  30. Freigang S, Ampenberger F, Weiss A et al (2013) Fatty acid-induced mitochondrial uncoupling elicits inflammasome- independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat Immunol 14(10):1045–1053

    Article  Google Scholar 

  31. Guzmán C, Benet M, Pisonero-Vaquero S et al (2013) The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim Biophys Acta 1831(4):803–818

    Article  Google Scholar 

  32. Varga T, Czimmerer Z, Nagy L (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 1812(8):1007–1022

    Article  Google Scholar 

  33. Qiu LX, Ye H, Chen LM et al (2012) Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARα. Phytother Res 26(6):860–864

    Article  Google Scholar 

  34. Mueller M, Hobiger S, Jungbauer A (2010) Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor α and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause 17(2):379–387

    Article  Google Scholar 

  35. Le NA, Brown WV (2011) Triglyceride-rich lipoproteins. In: Grundy SM (ed) Atlas of atherosclerosis and metabolic syndrome. Springer, New York, USA, pp 59–91

    Chapter  Google Scholar 

  36. Perona JS, Covas MI, Fitó M et al (2010) Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects. J Nutr Biochem 21(9):892–898

    Article  Google Scholar 

  37. Yang JH, Bang MA, Jang CH et al (2015) Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression. J Nutr Biochem 26(11):1393–1400

    Article  Google Scholar 

  38. Horton JD, Shah NA, Warrington JA et al (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 100(21):12027–12032

    Article  Google Scholar 

  39. Maxwell KN, Soccio RE, Duncan EM et al (2003) Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res 44(11):2109–2119

    Article  Google Scholar 

  40. Liu Q, Guo Y, Gui YJ et al (2016) Is sEHi lowering LDL-C by reducing expression of PCSK9 through SREBP2 pathway? Int J Cardiol 207:361–362

    Article  Google Scholar 

  41. Li H, Dong B, Park SW et al (2009) Hepatocyte nuclear factor 1α plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. J Biol Chem 284(42):28885–28895

    Article  Google Scholar 

  42. Dullaart RP, Annema W, Tio RA et al (2014) The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol. Clin Chim Acta 433(7):34–38

    Article  Google Scholar 

  43. De Fabiani E, Mitro N, Anzulovich AC et al (2001) The negative effects of bile acids and tumor necrosis factor-α on the transcription of cholesterol 7α-hydroxylase gene (cyp7a1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276(33):30708–30716

    Article  Google Scholar 

  44. Field FJ, Watt K, Mathur SN (2010) TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. J Lipid Res 51(6):1407–1415

    Article  Google Scholar 

  45. Khovidhunkit W, Moser AH, Shigenaga JK et al (2001) Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J Lipid Res 42(10):1636–1644

    Google Scholar 

  46. Wiriyaphan C, Xiao H, Decker EA et al (2015) Chemical and cellular antioxidative properties of threadfin bream (Nemipterus spp.) surimi byproduct hydrolysates fractionated by ultrafiltration. Food Chem 167(11):7–15

    Article  Google Scholar 

  47. Chi CF, Wang B, Wang YM et al (2015) Isolation and characterization of three antioxidant peptides from protein hydrolysate of bluefin leatherjacket (Navodon septentrionalis) heads. J Funct Foods 12:1–10

    Article  Google Scholar 

  48. Feng LJ, Yu CH, Ying KJ et al (2011) Hypolipidemic and antioxidant effects of total flavonoids of Perilla Frutescens leaves in hyperlipidemia rats induced by high-fat diet. Food Res Int 44(1):404–409

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by National Natural Science Foundation of China (Nos. 31571825, 31271979, and 31201245) and Natural Science Foundation of Tianjin, China (No. 15JCYBJC30100).

Author information

Author notes

  1. Zhaohui Xue and Ru Wang have contributed equally to this paper.

Authors and Affiliations

  1. School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, China

    Zhaohui Xue, Ru Wang, Haichao Wen & Xiaohong Kou

  2. Medical Plant Laboratory, Tianjin Research Center of Agricultural Biotechnology, Tianjin, 300381, China

    Wancong Yu

Authors
  1. Zhaohui Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ru Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haichao Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wancong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaohong Kou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaohong Kou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xue, Z., Wang, R., Wen, H. et al. Biochanin A and CPe-III Peptide Improved Hepatic Inflammation by Regulating the Hepatic Lipid Metabolic Pathways in Diet-Induced Obese Mice. Trans. Tianjin Univ. 24, 234–243 (2018). https://doi.org/10.1007/s12209-018-0117-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12209-018-0117-y

Keywords

Search

Navigation